Aaron from YMB: CYDY SUING 13D POINTS PT 2: 1) We now

New Post Public Reply Private Reply Replies (3) Message Board
Firelife619
1,370
Aaron from YMB:

CYDY SUING 13D POINTS PT 2:

1) We now have the answers from 13D. As I stated in my last post about the chancery court case, the accusations by Cytodyn against 13D were of a binary yes or no nature.

I will go through some later but basically 1) Are the facts stated by Cytodyn true? 2). Did 13D leave them out of their submission to investors?

The answer is yes and yes. There was no way for 13D counsel to deny it. This has left them with the only possible avenue to explore. While everything asserted is correct, it's not important or out of the hands of Patterson whose company made the decision without him (more on that later).

Many posters have noted these are horrible answers but under the circumstances it was all they had.

2) CASE WAS EXPEDITED.
Generally a case like this gets expedited because the judge has seen the preliminary evidence and believes that the decision is a forgone conclusion. If so, best to not waste the courts time and make a ruling.

Had the 13D response been to refute the facts that may have swayed the judge. But saying the facts are true but insubstantial I don't believe will cut well with this judge

This judge apparently has decades of experience in corporate law decisions and corporate bylaws. She saw something (the binary conclusion I mentioned before) that caused her to expedite the case.

The 13D response is basically, your eyes aren't deceiving you, it's your brain. None of those material facts are important!

I don't think that's going to hold much water.

3) NEXT STEP?

Most likely the next step is the judge is going to now throw the ball back to Sidley for a response/rebuttal to 13D's answer and she will make a judgement from that.

4) PATTERSON TALKS TOO MUCH

For all BP scientific knowledge he doesn't seem to know what most every American citizen knows. When involved in court proceedings, just shut up.

The argument that BP wasn't part of a buyout offer for Incelldx is practically refuted by BP's own tweet. He discusses it openly even mentioning a confidentiality that was broken so he can talk about it implying he was directly a party to the actions (This tweet was only last week SMH).

Cytodyn is suing for an injunction to silence the 13D and there is Patterson saying he is free to openly discuss matters now. He's practically making the case for Cytodyn that he needs to be muzzled.

But wait there is a lot more.

5) DID BP GET PAID FOR ASSAYS?

BP tweeted that he withheld the Assays because he didn't get paid. (I will link to it separately in the reply section so it doesn't pull this main post down).

It's been stated as fact in the Sidley documents submitted to court that BP was eventually getting $20,000 per month for his services. It seems BP felt the Assays were a separate deal

One can surmise where this went off the rails. BP demanding payment for Assays, NP asking what the hell he is paying $20K a month for?

So were the assays supposed to be separately billable?

The Assays would have been months of work. If BP felt he wasn't paid for months of work, one wonders why he didn't sue in court for non-payment of contracted work?

Ask yourself if you would have sued the company after performing months of labor and didn't get paid?

NP certainly has evidence of the monthly$20K arrangements. It looks more and more like BP simply withheld the Assays.

6) BP TIMELINE

A) BP getting paid $20K a month from Cytodyn

B) BP hyped Leronlimab even doing speaking engagements

C) BP tries to sell Incelldx for $350 million to Cytodyn and is rejected.

D) BP gets caught trying to patent Cytodyn tech.

E) BP withholds important Assays that will affect BLA submission.

F) BP doesn't sue for non-payment of Assays work even though he claims he is owed money

G) BP starts playing up Ivermectin and Maraviroc and downplaying Cytodyn.

H) BP signs onboard to 13D proxy battle.

I) BP involvement from the timeline above left out of 13D submission

Now how does this timeline look?

7) BP SP AFFECT

The OWS comments by BP may also be submitted in the Sidley response.

They caused a positive spike in the stock price as well as generating a number of articles. The info was incorrect as well but that's besides the point.

The point will be to show how the stock price jumped just on the single comments of BP.

Why is this pertinent? Cytodyn is claiming the 13D and BP need an injunction because they are affecting the SP. BP's OWS comments and the resultant SP spike go towards proof his words matter and the need for the injunction.

CONCLUSION:. None of this looks good for 13D. As this is simply to decide if an injunction is warranted I don't see this court battle taking too long to conclude.

BP saying he can talk about confidential agreement pertaining to sale of Incelldx

https://mobile.twitter.com/brucep13/status/14...0750248967

BP tweeting he withheld Assays

https://mobile.twitter.com/brucep13/status/14...0942012417
1

CytoDyn Inc (CYDY) Stock Research Links

CYDY Board Company Profile Buy Rating Time & Sales News Filings Financials
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Martin's Holiday Heatwave: Mixing Summer Flavors

Updated Category News Views 61

Holiday Heatwave Meets Winter Cheer with Martin's Rolls Hold onto your oven mitts, folks, because Martin’s Famous Potato Rolls and Bread is stirring up the winter doldrums with an unexpected twist this holiday season. Forget the old cranberry sauce routine—it’s all about mixing sunny vibes with frosty festivities in their "Very Merry Martin’s: Holiday Heatwave."...

Continue Reading
Reversing Early Tooth Decay: Insights from Dr. Sakurai

Updated Category News Views 35

Who would've thought your morning coffee ritual could be in cahoots with a silent tooth villain? Well, Dr. Kari Sakurai at Pacific View Smile Center slices through the noise with some fascinating insights on early tooth decay, spun out in an article by HelloNation. You see, Dr. Sakurai, like a dental James Bond, is fighting the good fight against cavities before they even...

Continue Reading
Boosting Heating Efficiency in Aging Massillon Homes

Updated Category News Views 58

Tackling the Age-Old Heating Puzzle Ah, the charm of an older home—from the creaky floors to the vintage architecture, it's something else. But, let's face it, keeping these houses warm can feel like patching up an old ship. Our man Reid Sittler, HVAC aficionado from Massillon, Ohio, shares some no-nonsense insights on how to stop your precious heat from slipping...

Continue Reading
Check Point Q3 2026 Results: Subtle Shifts or a Turning Point?

Updated Category News Views 159

Digging Deeper into Check Point's Latest Figures When Check Point Software Technologies Ltd. (NASDAQ:CHKP) throws numbers at the wall, not everything sticks, but there's always something telling. The Q3 financial results for 2026 are out, and it's a mixed bag—coffee’s getting cold before you parse through it. Revenue and Subscription Dynamics Let's cut to it: total...

Continue Reading
Potomac Edison Targets Virginia Grid Revamp by 2030

Updated Category News Views 60

Strengthening the Backbone of Virginia's Power Supply Ever had your lights flicker on a windy day and wondered if the power grid would hold? Potomac Edison, under the banner of FirstEnergy Corp., is stepping up with a game plan to fortify the electric spine of Virginia and its neighbors. They're diving into a multi-state adventure, rebuilding and erecting 138 kV...

Continue Reading
Emergys and Glean Rearrange AI Puzzle for Enterprises

Updated Category News Views 104

Enterprises on AI: From Dreams to Doing Alright, here’s a nugget for you: AI isn't just pie-in-the-sky jazz anymore. Some folks are finally bringing it down to Earth. Emergys, a player in digital transformation, is shaking hands with Glean, renowned for their enterprise AI chops, to turn enterprise chaos into clarity. It's all about squeezing out real returns and...

Continue Reading
Choice Hotels Hits Milestones and Faces Market Scrutiny

Updated Category News Views 265

Another Quarter Under the Belt Just when you think the hospitality industry's running out of steam, Choice Hotels International decides to shake things up. Reporting their third quarter 2026 results, the big picture here demands an attentive eye from investors. In the turbulent world of lodging franchises, NYSE:CHH is making waves, and I mean literal waves, as they surf...

Continue Reading
Exploring 'Deeper Prayer': A Journey with Apostle Paul

Updated Category News Views 90

A Deep Dive into the Prayers of Apostle Paul Gary P. Rohrmayer's latest devotional takes believers on a unique journey, exploring the Apostle Paul's prayers across his missionary paths. But don't expect just another preacher prophesying from the pulpit. This is more like peeling back layers of history, bit by bit. 28 Days of Spiritual Insights Each day within the book...

Continue Reading
Chemours Targets AI Cooling with Faizeon™ Launch

Updated Category News Views 44

Disruptive Cooling Technology in AI's Fast Lane The data centers that underpin our computational age are becoming sweatshops with all this AI-driven heat. Enter Chemours and its fresh Faizeon™ cooling fluid line, ready to be the unsung hero tackling the ever-mounting thermal loads from burgeoning AI and high-performance computing (HPC). These babies are designed to deal...

Continue Reading
Florida Cancer Institute Expands: New Oncologist Joins Team

Updated Category News Views 5

News in the medical world isn't just rattling desks today; it's a purposeful signal for cancer care's transformation. Florida Cancer Specialists & Research Institute (FCS) has beefed up its team, embracing Carlos Barbur, DO, an oncologist who's not just skilled but steeped in disciplines crucial for the health of many. Think of this as another puzzle piece fitting snugly...

Continue Reading

Top 5 Most Recently Viewed Articles

The Expanding Cannabis Market: Insights and Growth Trends

Updated Category News Views 279

The Expanding Cannabis Market: Insights and Growth Trends The cannabis market is on a remarkable trajectory, estimated to grow from USD 72.83 billion in 2025 to an impressive USD 125.76 billion by the year 2030. This growth signifies a compound annual growth rate (CAGR) of 11.5%, driven by various factors including increasing legalization, a surge in therapeutic demand,...

Continue Reading
Cycurion Expands Market Reach with New Contracts Worth $1 Million

Updated Category News Views 167

Cycurion Expands Market Reach with New Contracts Worth $1 Million MCLEAN, Va. — Cycurion (NASDAQ: CYCU), a prominent name in cybersecurity solutions, has marked a significant milestone by announcing five new contracts valued at around $1 million. These agreements, finalized in September, are poised to enhance the company’s growth trajectory, generating approximately...

Continue Reading
Knicks' Parade, Fed's Plan, and NYSE Buzz

Updated Category News Views 4

Unexpected Scene on Wall Street It's not your regular morning in New York when the city preps for a parade that's been five decades in the making. The New York Knicks, finally snapping their 53-year NBA title drought, are heading down the iconic Canyon of Heroes. For some, this might just be a sports milestone, but make no mistake, it's got a way of energizing the whole...

Continue Reading
SP Group's Strategic Decision to Enhance Future Operations

Updated Category News Views 115

SP Group Announces Closure of Accoat Production Facility SP Group, owning Accoat A/S as a subsidiary, has decided to terminate all production operations at its Kvistgaard facility within the next year. This strategic move is meant to align with the evolving objectives of the entire SP Group. Assessing the Impact of Production Phase-Out The winding down process is...

Continue Reading
The Transformative Impact of Musk's Starlink on Telecom Industry

Updated Category News Views 537

Elon Musk and the Future of Internet Access Telecom giants have long dominated the landscape of internet access, but a significant shift is now in progress. Renowned author and entrepreneur James Altucher has recently highlighted Elon Musk's Starlink as a revolutionary solution for internet connectivity. Altucher asserts that Starlink, with its network of satellites,...

Continue Reading